{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:17:23Z","timestamp":1787681843242,"version":"build-2784847793"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00213-022-06065-0","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T03:03:11Z","timestamp":1642820591000},"page":"1749-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT"],"prefix":"10.1007","volume":"239","author":[{"given":"Steven A.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"6065_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","volume":"4","author":"JS Aday","year":"2021","unstructured":"Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC (2021) Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects. ACS Pharmacol Transl Sci 4:424\u2013435. https:\/\/doi.org\/10.1021\/acsptsci.1c00014","journal-title":"ACS Pharmacol Transl Sci"},{"key":"6065_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","volume":"10","author":"RN Almeida","year":"2019","unstructured":"Almeida RN, Galv\u00e3o ACM, da Silva FS, Silva EAS, Palhano-Fontes F, Maia-de-Oliveira JP, de Ara\u00fajo DB, Lob\u00e3o-Soares B, Galv\u00e3o-Coelho NL (2019) Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial. Front Psychol 10:1234. https:\/\/doi.org\/10.3389\/fpsyg.2019.01234","journal-title":"Front Psychol"},{"key":"6065_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","volume":"143","author":"KAA Andersen","year":"2021","unstructured":"Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D (2021) Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies. Acta Psychiatr Scand 143:101\u2013118. https:\/\/doi.org\/10.1111\/acps.13249","journal-title":"Acta Psychiatr Scand"},{"key":"6065_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/02791072.1989.10472145","volume":"21","author":"W Andritzky","year":"1989","unstructured":"Andritzky W (1989) Sociopsychotherapeutic functions of ayahuasca healing in Amazonia. J Psychoactive Drugs 21:77\u201389. https:\/\/doi.org\/10.1080\/02791072.1989.10472145","journal-title":"J Psychoactive Drugs"},{"key":"6065_CR5","unstructured":"Arnold CM, Bhatt P, Slay S, Hartman MS, inventors. SW Holdings, assignee. Metered dosing compositions and methods of use of psychedelic compounds. World Int Property Org, 07\/01\/2021; WO 2021\/003467 Al"},{"key":"6065_CR6","doi-asserted-by":"publisher","unstructured":"Barker SA (2018a) N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function. Front Neurosci 12. https:\/\/doi.org\/10.3389\/fnins.2018.00536","DOI":"10.3389\/fnins.2018.00536"},{"key":"6065_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/0269881118767648","volume":"32","author":"SA Barker","year":"2018","unstructured":"Barker SA (2018b) N, N-dimethyltryptamine facts and myths. J Psychopharmacol 32:820\u2013822. https:\/\/doi.org\/10.1177\/0269881118767648","journal-title":"J Psychopharmacol"},{"key":"6065_CR8","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/0006-2952(82)90062-4","volume":"31","author":"SA Barker","year":"1982","unstructured":"Barker SA, Beaton JM, Christian ST, Monti JA, Morris PE (1982) Comparison of the brain levels of N, N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N, N-dimethyltryptamine following intraperitoneal injection: the in vivo kinetic isotope effect. Biochem Pharmacol 31:2513\u20132516. https:\/\/doi.org\/10.1016\/0006-2952(82)90062-4","journal-title":"Biochem Pharmacol"},{"key":"6065_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/0006-2952(84)90404-0","volume":"33","author":"SA Barker","year":"1984","unstructured":"Barker SA, Beaton JM, Christian ST, Monti JA, Morris PE (1984) In vivo metabolism of \u03b1, \u03b1, \u03b2, \u03b2-tetradeutero-N, N-dimethyltryptamine in rodent brain. Biochem Pharmacol 33:1395\u20131400. https:\/\/doi.org\/10.1016\/0006-2952(84)90404-0","journal-title":"Biochem Pharmacol"},{"key":"6065_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/bmc.2981","volume":"27","author":"SA Barker","year":"2013","unstructured":"Barker SA, Borjigin J, Lomnicka I, Strassman R (2013) LC\/MS\/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate. Biomed Chromatogr 27:1690\u20131700. https:\/\/doi.org\/10.1002\/bmc.2981","journal-title":"Biomed Chromatogr"},{"key":"6065_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/dta.422","volume":"4","author":"SA Barker","year":"2012","unstructured":"Barker SA, McIlhenny EH, Strassman R (2012) A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955\u20132010. Drug Test Anal 4:617\u2013635. https:\/\/doi.org\/10.1002\/dta.422","journal-title":"Drug Test Anal"},{"key":"6065_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0074-7742(08)60291-3","volume":"22","author":"SA Barker","year":"1981","unstructured":"Barker SA, Monti JA, Christian ST (1981) N, N-dimethyltryptamine: an endogenous hallucinogen. Int Rev Neurobiol 22:83\u2013110. https:\/\/doi.org\/10.1016\/S0074-7742(08)60291-3","journal-title":"Int Rev Neurobiol"},{"key":"6065_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0091-3057(82)90240-4","volume":"16","author":"JM Beaton","year":"1982","unstructured":"Beaton JM, Barker SA, Liu WF (1982) A comparison of the behavioral effects of proteo- and deutero-N, N-dimethyltryptamine. Pharmacol Biochem Behav 16:811\u2013814. https:\/\/doi.org\/10.1016\/0091-3057(82)90240-4","journal-title":"Pharmacol Biochem Behav"},{"key":"6065_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0047-6374(84)90007-1","volume":"25","author":"JM Beaton","year":"1984","unstructured":"Beaton JM, Morris PE (1984) Ontogeny of N, N-dimethyltryptamine and related indolealkylamine levels in neonatal rats. Mech Ageing Dev 25:343\u2013347. https:\/\/doi.org\/10.1016\/0047-6374(84)90007-1","journal-title":"Mech Ageing Dev"},{"key":"6065_CR15","first-page":"397","volume":"2","author":"F Benington","year":"1965","unstructured":"Benington F, Morin RD, Clark LC (1965) 5-methoxy-N, N-dimethyltryptamine, a possible endogenous psychotoxin. Ala J Med Sci 2:397\u2013403","journal-title":"Ala J Med Sci"},{"key":"6065_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1073858407305850","volume":"14","author":"P Bekinschtein","year":"2008","unstructured":"Bekinschtein P, Cammarota M, Izquierdo I, Medina JH (2008) Review: BDNF and memory formation and storage. Neuroscientist 14:147. https:\/\/doi.org\/10.1177\/1073858407305850","journal-title":"Neuroscientist"},{"key":"6065_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.neuropharm.2013.04.024","volume":"76","author":"P Bekinschtein","year":"2014","unstructured":"Bekinschtein P, Cammarota M, Medina JH (2014) BDNF and Memory Processing Neuropharm 76:677\u2013683. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.024","journal-title":"BDNF and Memory Processing Neuropharm"},{"key":"6065_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0014-2999(83)90253-4","volume":"90","author":"OG Berge","year":"1983","unstructured":"Berge OG, Chacho D, Hole K (1983) Inhibitory effect of 5-methoxy- N, N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine. Eur J Pharmacol 90:293\u2013296. https:\/\/doi.org\/10.1016\/0014-2999(83)90253-4","journal-title":"Eur J Pharmacol"},{"key":"6065_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","volume":"86","author":"AK Bershad","year":"2019","unstructured":"Bershad AK, Schepers ST, Bremmer MP, Lee R, de Wit H (2019) Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers. Biol Psychiat 86:792\u2013800. https:\/\/doi.org\/10.1016\/j.biopsych.2019.05.019","journal-title":"Biol Psychiat"},{"key":"6065_CR20","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s00213-014-3557-7","volume":"231","author":"BE Blough","year":"2014","unstructured":"Blough BE, Landavazo A, Decker AM, Partilla JS, Bauman MH (2014) Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacol 231:4135\u20134144. https:\/\/doi.org\/10.1007\/s00213-014-3557-7","journal-title":"Psychopharmacol"},{"key":"6065_CR21","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1073\/pnas.1308285110","volume":"110","author":"J Borjigin","year":"2013","unstructured":"Borjigin J et al (2013) Surge of neurophysiological coherence and connectivity in the dying brain. Proc Natl Acad Sci USA 110:14432\u201314437. https:\/\/doi.org\/10.1073\/pnas.1308285110","journal-title":"Proc Natl Acad Sci USA"},{"key":"6065_CR22","unstructured":"Boulton, AA and Yu, PH (1981) Deamination of some deuterated trace amines. Amer Soc Neurochem 12th Ann Meeting, p 197"},{"key":"6065_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pnpbp.2012.06.001","volume":"39","author":"DI Brierley","year":"2012","unstructured":"Brierley DI, Davidson C (2012) Developments in harmine pharmacology - implications for ayahuasca use and drug-dependence treatment. Prog Neuro-Psychopharmacol Biol Psychiat 39:263\u2013272. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.001","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiat"},{"key":"6065_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","volume":"79","author":"SA Burchett","year":"2006","unstructured":"Burchett SA, Hicks TP (2006) The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79:223\u2013246. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.07.003","journal-title":"Prog Neurobiol"},{"key":"6065_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2010.03.015","volume":"111","author":"V Cakic","year":"2010","unstructured":"Cakic V, Potkonyak J, Marshall A (2010) Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug Alcohol Depend 111:30\u201337. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.03.015","journal-title":"Drug Alcohol Depend"},{"key":"6065_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0378-8741(98)00168-8","volume":"65","author":"JC Callaway","year":"1999","unstructured":"Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC (1999) Pharmacokinetics of hoasca alkaloids in healthy humans. J Ethnopharmacol 65:243\u2013256. https:\/\/doi.org\/10.1016\/s0378-8741(98)00168-8","journal-title":"J Ethnopharmacol"},{"key":"6065_CR27","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","volume":"10","author":"LP Cameron","year":"2019","unstructured":"Cameron LP, Benson CJ, DeFelice BC, Fiehn O, Olson DE (2019) Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem Neurosci 10:3261\u20133270. https:\/\/doi.org\/10.1021\/acschemneuro.8b00692","journal-title":"ACS Chem Neurosci"},{"key":"6065_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Benson CJ, Dunlap LE, Olson DE (2018) Effects of N, N-dimethyltryptamine (DMT) on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci 9:1582\u20131590. https:\/\/doi.org\/10.1021\/acschemneuro8b00134","journal-title":"ACS Chem Neurosci"},{"key":"6065_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/02791072.2020.1718250","volume":"52","author":"LP Cameron","year":"2020","unstructured":"Cameron LP, Nazarian A, Olson DE (2020) Psychedelic microdosing: prevalence and subjective effects. J Psycho Drugs 52:113\u2013122. https:\/\/doi.org\/10.1080\/02791072.2020.1718250","journal-title":"J Psycho Drugs"},{"key":"6065_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","volume":"126","author":"TM Carbonaro","year":"2016","unstructured":"Carbonaro TM, Gatch MB (2016) Neuropharmacology of N, N-dimethyltryptamine. Brain Res Bull 126:74\u201388. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.016","journal-title":"Brain Res Bull"},{"key":"6065_CR31","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Goodwin GM (2017) The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42:2105\u20132113. https:\/\/doi.org\/10.1038\/npp.2017.84","journal-title":"Neuropsychopharmacology"},{"key":"6065_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0006-2944(75)90036-8","volume":"14","author":"ST Christian","year":"1975","unstructured":"Christian ST, Benington F, Morin RD, Corbett L (1975) Gas\u2013liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluid. Biochem Med 14:191\u2013200. https:\/\/doi.org\/10.1016\/0006-2944(75)90036-8","journal-title":"Biochem Med"},{"key":"6065_CR33","first-page":"162","volume":"13","author":"ST Christian","year":"1976","unstructured":"Christian ST, Harrison R, Pagel J (1976) Evidence for dimethyltryptamine (DMT) as a naturally occurring transmitter in mammalian brain. Ala J Med Sci 13:162\u2013165","journal-title":"Ala J Med Sci"},{"key":"6065_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0006-2944(77)90088-6","volume":"18","author":"S Christian","year":"1977","unstructured":"Christian S, Harrison R, Quayle E, Pagel J, Monti J (1977) The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochem Med 18:164\u2013183. https:\/\/doi.org\/10.1016\/0006-2944(77)90088-6","journal-title":"Biochem Med"},{"key":"6065_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/13543776.2013.769522","volume":"23","author":"S Collina","year":"2013","unstructured":"Collina S, Gaggeri R, Marra A, Bass A, Negrinotti S, Negri F et al (2013) Sigma receptor modulators: a patent review. Expert Opin Ther Pat 23:597\u2013613. https:\/\/doi.org\/10.1517\/13543776.2013.769522","journal-title":"Expert Opin Ther Pat"},{"key":"6065_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1192\/bjp.132.2.139","volume":"132","author":"L Corbett","year":"1978","unstructured":"Corbett L, Christian ST, Morin RD, Benington F, Smythies JR (1978) Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric control populations. Br J Psychiatr 132:139\u2013144. https:\/\/doi.org\/10.1192\/bjp.132.2.139","journal-title":"Br J Psychiatr"},{"key":"6065_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","volume":"116","author":"NV Cozzi","year":"2009","unstructured":"Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116:1591\u20131599. https:\/\/doi.org\/10.1007\/s00702-009-0308-8","journal-title":"J Neural Transm"},{"key":"6065_CR38","unstructured":"Cozzi NV, Mavlyutov TA, Thompson MA, Ruoho A (2011) Indolethylamine N-methyltransferase expression in primate nervous tissue. Soc Neurosci Abstr"},{"key":"6065_CR39","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3390\/molecules26092451","volume":"26","author":"P Cumming","year":"2021","unstructured":"Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C (2021) Molecular and functional imaging studies of psychedelic drug action in animals and humans. Molecules 26:2451. https:\/\/doi.org\/10.3390\/molecules26092451","journal-title":"Molecules"},{"key":"6065_CR40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1177\/0269881120916143","volume":"34","author":"AK Davis","year":"2020","unstructured":"Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR (2020) Survey of entity encounter experiences occasioned by inhaled N, N-dimethyltryptamine: phenomenology, interpretation, and enduring effects. J Psychopharmacol 34:1008\u20131020. https:\/\/doi.org\/10.1177\/0269881120916143","journal-title":"J Psychopharmacol"},{"key":"6065_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0378-8741(83)90031-4","volume":"9","author":"PA De Smet","year":"1983","unstructured":"De Smet PA (1983) A multidisciplinary overview of intoxicating enema rituals in the Western hemisphere. J Ethnopharmacol 9:129\u2013166. https:\/\/doi.org\/10.1016\/0378-8741(83)90031-4","journal-title":"J Ethnopharmacol"},{"key":"6065_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnins.2018.00232","volume":"12","author":"JG Dean","year":"2018","unstructured":"Dean JG (2018) Indolethylamine-N-methyltransferase polymorphisms: genetic and biochemical approaches for study of endogenous N. N-Dimethyltryptamine Front Neurosci 12:232. https:\/\/doi.org\/10.3389\/fnins.2018.00232","journal-title":"N-Dimethyltryptamine Front Neurosci"},{"key":"6065_CR43","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","volume":"9","author":"JG Dean","year":"2019","unstructured":"Dean JG, Liu T, Huff S, Sheler B, Barker SA, Strassman RJ, Wang MM, Borjigin J (2019) Biosynthesis and extracellular concentrations of N, N-dimethyltryptamine (DMT) in mammalian brain. Sci Reports 9:9333. https:\/\/doi.org\/10.1038\/s41598-019-45812-w","journal-title":"Sci Reports"},{"key":"6065_CR44","unstructured":"Dean, J (2017) Micro-dosing: The drug habit your boss is gonna love. GQ Retrieved from https:\/\/www.gq.com\/story\/micro-dosing-lsd July 29, 2021."},{"key":"6065_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuroscience.2008.01.012","volume":"152","author":"DA DeSteno","year":"2008","unstructured":"DeSteno DA, Schmauss C (2008) Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting task. Neurosci 152:417\u2013428. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.01.012","journal-title":"Neurosci"},{"key":"6065_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/JCP.0b013e31823607f6","volume":"31","author":"RG dos Santos","year":"2011","unstructured":"dos Santos RG, Valle M, Bouso JC, Nomded\u00e9u JF, Rodr\u00edguez-Espinosa J, McIlhenny EH, Barker SA, Barbanoj MJ, Riba J (2011) Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol 31:717\u2013726. https:\/\/doi.org\/10.1097\/JCP.0b013e31823607f6","journal-title":"J Clin Psychopharmacol"},{"key":"6065_CR47","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1177\/0269881116652578","volume":"30","author":"RG dos Santos","year":"2016","unstructured":"dos Santos RG, Balthazar FM, Bouso JC, Hallak JEC (2016a) The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. J Psychopharmacol 30:1230\u20131247. https:\/\/doi.org\/10.1177\/0269881116652578","journal-title":"J Psychopharmacol"},{"key":"6065_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/2045125316638008","volume":"6","author":"RG dos Santos","year":"2016","unstructured":"dos Santos RG, Oso\u0155io FL, Crippa JAS, Riba J, Zuardi AW, Hallak JEC (2016b) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol 6:193\u2013213. https:\/\/doi.org\/10.1177\/2045125316638008","journal-title":"Ther Adv Psychopharmacol"},{"key":"6065_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/2045125316689030","volume":"7","author":"RG dos Santos","year":"2017","unstructured":"dos Santos RG, Bouso JC, Hallak JEC (2017) Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol 7:141\u2013157. https:\/\/doi.org\/10.1177\/2045125316689030","journal-title":"Ther Adv Psychopharmacol"},{"key":"6065_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/17512433.2018.1511424","volume":"11","author":"RG dos Santos","year":"2018","unstructured":"dos Santos RG, Bouso JC, Alc\u00e1zar-C\u00f3rcoles MA, Hallak JEC (2018) Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol 11:889\u2013902. https:\/\/doi.org\/10.1080\/17512433.2018.1511424","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6065_CR51","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/RMHP.S300656","volume":"14","author":"RG dos Santos","year":"2021","unstructured":"dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE (2021) The use of classic hallucinogens\/psychedelics in a therapeutic context: healthcare policy opportunities and challenges. Risk Manag Healthcare Pol 14:901\u2013910. https:\/\/doi.org\/10.2147\/RMHP.S300656","journal-title":"Risk Manag Healthcare Pol"},{"key":"6065_CR52","doi-asserted-by":"publisher","unstructured":"Dunlap LE, Azinfar A, Ly C, et al. (2020) Identification of psychoplastogenic N,N-dimethylaminoisotryptamine (isoDMT) analogues through structure\u2013activity relationship studies J Med Chem 63:1142\u20131155. doi: https:\/\/doi.org\/10.1021\/acs.jmedchem.9b0140","DOI":"10.1021\/acs.jmedchem.9b0140"},{"key":"6065_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","volume":"51","author":"J Fadiman","year":"2019","unstructured":"Fadiman J, Korb S (2019) Might microdosing psychedelics be safe and beneficial? An initial exploration. J Psychoact Drugs 51:118\u2013122. https:\/\/doi.org\/10.1080\/02791072.2019.1593561","journal-title":"J Psychoact Drugs"},{"key":"6065_CR54","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.neubiorev.2009.04.003","volume":"33","author":"PJ Fitzgerald","year":"2009","unstructured":"Fitzgerald PJ (2009) Neuromodulating mice and men: are there functional species differences in neurotransmitter concentration? Neurosci Biobehav Rev 33:1037\u20131041. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.04.003","journal-title":"Neurosci Biobehav Rev"},{"key":"6065_CR55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.1166127","volume":"323","author":"D Fontanilla","year":"2009","unstructured":"Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323:934\u2013937. https:\/\/doi.org\/10.1126\/science.1166127","journal-title":"Science"},{"key":"6065_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0006-8993(02)03548-5","volume":"958","author":"PS Frankel","year":"2002","unstructured":"Frankel PS, Cunningham KA (2002) The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain. Brain Res 958:251\u2013260. https:\/\/doi.org\/10.1016\/s0006-8993(02)03548-5","journal-title":"Brain Res"},{"key":"6065_CR57","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","volume":"120","author":"E Frecska","year":"2013","unstructured":"Frecska E, Szabo A, Winkelman MJ, Luna LE, McKenna DJ (2013) A possible sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm 120:1295\u20131303. https:\/\/doi.org\/10.1007\/s00702-013-1024-y","journal-title":"J Neural Transm"},{"key":"6065_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fphar.2016.00035","volume":"7","author":"E Frecska","year":"2016","unstructured":"Frecska E, Bokor P, Winkelman M (2016) The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization. Front Pharmacol 7:35. https:\/\/doi.org\/10.3389\/fphar.2016.00035","journal-title":"Front Pharmacol"},{"key":"6065_CR59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2019.05.019","volume":"70","author":"J Gardner","year":"2019","unstructured":"Gardner J, Carter A, O\u2019Brien K, Seear K (2019) Psychedelic-assisted therapies: the past, and the need to move forward responsibly. Inter J Drug Pol 70:94\u201398. https:\/\/doi.org\/10.1016\/j.drugpo.2019.05.019","journal-title":"Inter J Drug Pol"},{"key":"6065_CR60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/ajp.133.2.203","volume":"133","author":"JC Gillin","year":"1976","unstructured":"Gillin JC, Kaplan J, Stillman R, Wyatt RJ (1976) The psychedelic model of schizophrenia: the case of N, N-dimethyltryptamine. Am J Psychiat 133:203\u2013208. https:\/\/doi.org\/10.1176\/ajp.133.2.203","journal-title":"Am J Psychiat"},{"key":"6065_CR61","unstructured":"Glatter, R (2015) LSD microdosing: the new job enhancer in Silicon Valley and beyond? Forbes https:\/\/www.forbes.com\/sites\/robertglatter\/2015\/11\/27\/lsd-microdosingthe-new-job-enhancer-in-silicon-valley-and-beyond\/#19aa3042188a. Accessed July 7, 2021."},{"key":"6065_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","unstructured":"Gonz\u00e1lez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R et al (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor mediated signaling pathways to affect behavior. Neuron 53:439\u2013452. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.008","journal-title":"Neuron"},{"key":"6065_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/jexpneurol201206030","volume":"237","author":"E Griesmaier","year":"2012","unstructured":"Griesmaier E, Posod A, Gross M, Neubauer V, Wegleiter K, Hermann M et al (2012) Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice. Exp Neurol 237:388\u2013395. https:\/\/doi.org\/10.1016\/jexpneurol201206030","journal-title":"Exp Neurol"},{"key":"6065_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00213-008-1247-z","volume":"201","author":"AL Halberstadt","year":"2008","unstructured":"Halberstadt AL, Buell MR, Masten VL, Brisbrough V, Geyer MA (2008) Modification of the effects of 5-methoxy-N, N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacol (Ber) 201:55\u201366. https:\/\/doi.org\/10.1007\/s00213-008-1247-z","journal-title":"Psychopharmacol (Ber)"},{"key":"6065_CR65","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00213-011-2616-6","volume":"221","author":"AL Halberstadt","year":"2012","unstructured":"Halberstadt AL, Nichols DE, Geyer MA (2012) Behavioral effects of \u03b1, \u03b1, \u03b2, \u03b2-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacol 221:709\u2013718. https:\/\/doi.org\/10.1007\/s00213-011-2616-6","journal-title":"Psychopharmacol"},{"key":"6065_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","volume":"277","author":"AL Halberstadt","year":"2015","unstructured":"Halberstadt AL (2015) Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 277:99\u2013120. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.016","journal-title":"Behav Brain Res"},{"key":"6065_CR67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","volume":"22","author":"NR Hutten","year":"2019","unstructured":"Hutten NR, Mason NL, Dolder PC, Kuypers KP (2019) Motives and side-effects of microdosing with psychedelics among users. Inter J Neuropsychopharmacol 22:426\u2013434. https:\/\/doi.org\/10.1093\/ijnp\/pyz029","journal-title":"Inter J Neuropsychopharmacol"},{"key":"6065_CR68","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","volume":"73","author":"A Inserra","year":"2020","unstructured":"Inserra A, De Gregorio D, Gobbi G (2020) Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms. Pharmacol Rev 73:202\u2013277. https:\/\/doi.org\/10.1124\/pharmrev.120.000056","journal-title":"Pharmacol Rev"},{"key":"6065_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/85138","volume":"4","author":"MW Jones","year":"2001","unstructured":"Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4:289\u2013296. https:\/\/doi.org\/10.1038\/85138","journal-title":"Nat Neurosci"},{"key":"6065_CR70","doi-asserted-by":"publisher","unstructured":"Kaasik H, Souza RCZ, Zandonadi FS, T\u00f3foli LF, Sussulini A (2020) Chemical composition of traditional and analog ayahuasca. J Psychoact Drugs 1\u201311. https:\/\/doi.org\/10.1080\/0279107220201815911","DOI":"10.1080\/0279107220201815911"},{"key":"6065_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/00365510510013604","volume":"65","author":"J Karkkainen","year":"2005","unstructured":"Karkkainen J, Forsstrom T, Tornaeus J, Wahala K, Kiuru P, Honkanen A, Stenman UH, Turpeinen U, Hesso A (2005) Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest 65:189\u2013199. https:\/\/doi.org\/10.1080\/00365510510013604","journal-title":"Scand J Clin Lab Invest"},{"key":"6065_CR72","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/jtins201209007","volume":"35","author":"S Kourrich","year":"2012","unstructured":"Kourrich S, Su TP, Fujimoto M, Bonci A (2012) The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci 35:762\u2013771. https:\/\/doi.org\/10.1016\/jtins201209007","journal-title":"Trends Neurosci"},{"key":"6065_CR73","doi-asserted-by":"publisher","first-page":"204512532095056","DOI":"10.1177\/2045125320950567","volume":"10","author":"KPC Kuypers","year":"2020","unstructured":"Kuypers KPC (2020) The therapeutic potential of microdosing psychedelics in depression. Ther Adv Psychopharmacol 10:2045125320950567. https:\/\/doi.org\/10.1177\/2045125320950567","journal-title":"Ther Adv Psychopharmacol"},{"key":"6065_CR74","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0269881119857204","volume":"33","author":"KPC Kuypers","year":"2019","unstructured":"Kuypers KPC, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE et al (2019) Microdosing psychedelics: more questions than answers? An overview and suggestions for future research. J Psychopharmacol 33:1039\u20131057. https:\/\/doi.org\/10.1177\/0269881119857204","journal-title":"J Psychopharmacol"},{"key":"6065_CR75","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00213-016-4377-8","volume":"233","author":"KPC Kuypers","year":"2016","unstructured":"Kuypers KPC, Riba J, Revenga MF, Barker SA, Theunissen EL, Ramaekers JG (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacol (ber) 233:3395\u20133403. https:\/\/doi.org\/10.1007\/s00213-016-4377-8","journal-title":"Psychopharmacol (ber)"},{"key":"6065_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.11.008","volume":"75","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H, Schecke H, Klein M (2020) Microdosing psychedelics: motivations, subjective effects and harm reduction. Int J Drug Policy 75:102600. https:\/\/doi.org\/10.1016\/j.drugpo.2019.11.008","journal-title":"Int J Drug Policy"},{"key":"6065_CR77","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.brainres.2014.10.019","volume":"1621","author":"G Leal","year":"2015","unstructured":"Leal G, Afonso PM, Salazar IL, Duarte CB (2015) Regulation of hippocampal synaptic plasticity by BDNF. Brain Res 1621:82\u2013101. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.019","journal-title":"Brain Res"},{"key":"6065_CR78","doi-asserted-by":"publisher","first-page":"E2073","DOI":"10.1073\/pnas.1423936112Asphyxia-activatedcorticocardiacsignalingacceleratesonsetofcardiacarrest","volume":"112","author":"D Li","year":"2015","unstructured":"Li D, Mabrouk OS, Liu T et al (2015) Asphyxia-activated corticocardiac signaling accelerates onset of cardiac arrest. Proc Nat Acad Sci 112:E2073\u2013E2082. https:\/\/doi.org\/10.1073\/pnas.1423936112Asphyxia-activatedcorticocardiacsignalingacceleratesonsetofcardiacarrest","journal-title":"Proc Nat Acad Sci"},{"key":"6065_CR79","first-page":"1052","volume":"33","author":"ME Liechti","year":"2019","unstructured":"Liechti ME (2019) Psychedelics: what are low doses and \u2018microdoses\u2019? Commentary on Kuypers et al. (2019). Journal of Psychopharmacology 33:1052\u20131053","journal-title":"Journal of Psychopharmacology"},{"key":"6065_CR80","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/dev.420070511","volume":"7","author":"RL Lin","year":"1974","unstructured":"Lin RL, Sargeant S, Narasimhachari N (1974) Indolethylamine-N-methyltransferase in developing rabbit lung. Dev Psychobiol 7:475\u2013481. https:\/\/doi.org\/10.1002\/dev.420070511","journal-title":"Dev Psychobiol"},{"key":"6065_CR81","doi-asserted-by":"publisher","unstructured":"Lu B, Nagappan G, Lu Y (2014) BDNF and synaptic plasticity, cognitive function, and dysfunction. In: Lewin G., Carter B. (eds) Neurotrophic factors. Handbook of experimental pharmacology, vol 220. Springer: Berlin. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_9","DOI":"10.1007\/978-3-642-45106-5_9"},{"key":"6065_CR82","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","volume":"52","author":"JB Luoma","year":"2020","unstructured":"Luoma JB, Chwyl C, Bathje GJ, Davis AK, Lancelotta R (2020) A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. J Psychoact Drugs 52:289\u2013299. https:\/\/doi.org\/10.1080\/02791072.2020.1769878","journal-title":"J Psychoact Drugs"},{"key":"6065_CR83","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, Duim WC, Dennis MY, McAllister AK, Ori-McKenney KM, Gray JA, Olson DE (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep 23:3170\u20133182","journal-title":"Cell Rep"},{"key":"6065_CR84","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/7854_2017_479","volume":"36","author":"DA Martin","year":"2017","unstructured":"Martin DA, Nichols CD (2017) The effects of hallucinogens on gene expression. Curr Top Behav Neurosci 36:137\u2013158. https:\/\/doi.org\/10.1007\/7854_2017_479","journal-title":"Curr Top Behav Neurosci"},{"key":"6065_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.03.013","volume":"83","author":"DA Martin","year":"2014","unstructured":"Martin DA, Marona-Lewicka D, Nichols DE, Nichols CD (2014) Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia. Neuropharmacol 83:1\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.013","journal-title":"Neuropharmacol"},{"key":"6065_CR86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroscience.2011.12.040","volume":"206","author":"TA Mavlyutov","year":"2012","unstructured":"Mavlyutov TA, Epstein ML, Liu P, Verbny YA, Conhaim LZ, Ruoho AE (2012) Development of the sigma-1 receptor in c-terminals of motoneurons and colocalization with the N, N-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neurosci 206:60\u201368. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.12.040","journal-title":"Neurosci"},{"key":"6065_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","volume":"102","author":"DJ McKenna","year":"2004","unstructured":"McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Therap 102:111. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.03.002","journal-title":"Pharmacol Therap"},{"key":"6065_CR88","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GHN, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 10:195\u2013223. https:\/\/doi.org\/10.1016\/0378-8741(84)90003-5","journal-title":"J Ethnopharmacol"},{"key":"6065_CR89","first-page":"65","volume":"1","author":"DJ McKenna","year":"1998","unstructured":"McKenna DJ, Callaway JC, Grob CS (1998) The scientific investigation of ayahuasca: a review of past and current research. Heffter Rev Psychedel Res 1:65\u201377","journal-title":"Heffter Rev Psychedel Res"},{"key":"6065_CR90","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","volume":"10","author":"JA Morales-Garcia","year":"2020","unstructured":"Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA, Alonso-Gil S, Sanz-SanCristobal M, Riba J, Perez-Castillo A (2020) N, N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiat 10:331. https:\/\/doi.org\/10.1038\/s41398-020-01011-0","journal-title":"Transl Psychiat"},{"key":"6065_CR91","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/JLCR.2580330603","volume":"33","author":"P Morris","year":"1993","unstructured":"Morris P, Chiao C (1993) Indolealkylamine metabolism: synthesis of deuterated indolealkylamines as metabolic probes. J Label Comp Radiopharm 33:455\u2013465. https:\/\/doi.org\/10.1002\/JLCR.2580330603","journal-title":"J Label Comp Radiopharm"},{"issue":"2019","key":"6065_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","volume":"258","author":"S Muttoni","year":"2019","unstructured":"Muttoni S, Ardissino M, John C (2019) Classical psychedelics for the treatment of depression and anxiety: a systematic review. J Affect Disorders 258(2019):11\u201324. https:\/\/doi.org\/10.1016\/j.jad.2019.07.076","journal-title":"J Affect Disorders"},{"key":"6065_CR93","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/jejphar200611075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh K, Kamimura H (2007) The effects of nonmedically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132\u2013137. https:\/\/doi.org\/10.1016\/jejphar200611075","journal-title":"Eur J Pharmacol"},{"key":"6065_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113245","volume":"327","author":"S Nardai","year":"2020","unstructured":"Nardai S, L\u00e1szl\u00f3a M, Szab\u00f3 A, Alp\u00e1rc A, Hanics J, Zaholac P, Merkelya B, Frecska E, Nagya Z (2020) N, N-dimethyltryptamine. Exper Neurol 327:113245. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113245","journal-title":"Exper Neurol"},{"key":"6065_CR95","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.transproceed.2019.04.005","volume":"51","author":"B Nemes","year":"2019","unstructured":"Nemes B, Peto K, Nemeth N et al (2019) N, N-dimethyltryptamine prevents renal ischemia-reperfusion injury in a rat model. Transplant Proc 51:1268\u20131275. https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.005","journal-title":"Transplant Proc"},{"key":"6065_CR96","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41380-019-0639-2","volume":"25","author":"M Notaras","year":"2020","unstructured":"Notaras M, van den Buuse M (2020) Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders. Mol Psychiat 25:2251\u20132274. https:\/\/doi.org\/10.1038\/s41380-019-0639-2","journal-title":"Mol Psychiat"},{"key":"6065_CR97","first-page":"16","volume":"4","author":"CD Nichols","year":"2020","unstructured":"Nichols CD, Nichols DE (2020) DMT in the mammalian brain: a critical appraisal. ALIUS Bull 4:16\u201322","journal-title":"ALIUS Bull"},{"key":"6065_CR98","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/jpharmthera200311002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181. https:\/\/doi.org\/10.1016\/jpharmthera200311002","journal-title":"Pharmacol Ther"},{"key":"6065_CR99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"key":"6065_CR100","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0269881117736919","volume":"32","author":"DE Nichols","year":"2018","unstructured":"Nichols DE (2018a) N, N-dimethyltryptamine and the pineal gland: separating fact from myth. J Psychopharmacol 32:30\u201336. https:\/\/doi.org\/10.1177\/0269881117736919","journal-title":"J Psychopharmacol"},{"key":"6065_CR101","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/0269881118767648","volume":"32","author":"DE Nichols","year":"2018","unstructured":"Nichols DE (2018b) N, N-dimethyltryptamine facts and myths: author\u2019s reply. J Psychopharmacol 32:820\u2013822. https:\/\/doi.org\/10.1177\/0269881118767648","journal-title":"J Psychopharmacol"},{"key":"6065_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1556\/2054.2019.018","volume":"4","author":"T Noorani","year":"2020","unstructured":"Noorani T (2020) Making psychedelics into medicines: the politics and paradoxes of medicalization. J Psychedel Stud 4:34\u201339. https:\/\/doi.org\/10.1556\/2054.2019.018","journal-title":"J Psychedel Stud"},{"key":"6065_CR103","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1152\/physiolgenomics.00189.2010","volume":"44","author":"M Nuno-Ayala","year":"2012","unstructured":"Nuno-Ayala M, Guillen N, Arnal C, Lou-Bonafonte JM, de Martino A, Garcia-de-Jalon JA, Gascon S, Osaba L, Osada J, Navarro MA (2012) Cystathionine b-synthase deficiency causes infertility by impairing decidualization and gene expression networks in uterus implantation sites. Physiol Genomics 44:702\u2013716. https:\/\/doi.org\/10.1152\/physiolgenomics.00189.2010","journal-title":"Physiol Genomics"},{"key":"6065_CR104","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-3-319-50174-1_10","volume":"964","author":"L Nguyen","year":"2017","unstructured":"Nguyen L, Lucke-Wold BP, Mookerjee S, Kaushal N, Matsumoto RR (2017) Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection. Adv Exp Med Biol 964:133\u2013152. https:\/\/doi.org\/10.1007\/978-3-319-50174-1_10","journal-title":"Adv Exp Med Biol"},{"key":"6065_CR105","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0166-2236(98)01343-5","volume":"22","author":"KJ O\u2019Donovan","year":"1999","unstructured":"O\u2019Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM (1999) The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 22:167\u2013173. https:\/\/doi.org\/10.1016\/s0166-2236(98)01343-5","journal-title":"Trends Neurosci"},{"key":"6065_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson DE (2018) Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics. J Exper Neurosci 12:1\u20134. https:\/\/doi.org\/10.1177\/1179069518800508","journal-title":"J Exper Neurosci"},{"key":"6065_CR107","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","volume":"4","author":"DE Olson","year":"2021","unstructured":"Olson DE (2021) The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacol Transl Sci 4:563\u2013567. https:\/\/doi.org\/10.1021\/acsptsci.0c00192","journal-title":"ACS Pharmacol Transl Sci"},{"key":"6065_CR108","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1021\/acschemneuro.0c00614","volume":"11","author":"G Ona","year":"2020","unstructured":"Ona G, dos Santos RG, Hallak JEC, Bouso JC (2020) Polypharmacology or \u201cpharmacological promiscuity\u201d in psychedelic research: what are we missing? ACS Chem Neurosci 11:3191\u20133193. https:\/\/doi.org\/10.1021\/acschemneuro.0c00614","journal-title":"ACS Chem Neurosci"},{"key":"6065_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1192\/bjp.98.411.309","volume":"98","author":"H Osmond","year":"1952","unstructured":"Osmond H, Smythies JR (1952) Schizophrenia: a new approach. J Ment Sci 98:309\u2013315. https:\/\/doi.org\/10.1192\/bjp.98.411.309","journal-title":"J Ment Sci"},{"key":"6065_CR110","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","volume":"37","author":"F Os\u00f3rio","year":"2015","unstructured":"Os\u00f3rio F, Sanches R, Macedo L, dos Santos R, Maia-de-Oliveira J, Wichert-Ana L et al (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr 37:13\u201320","journal-title":"Rev Bras Psiquiatr"},{"key":"6065_CR111","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02791072.1999.10471741","volume":"31","author":"J Ott","year":"1999","unstructured":"Ott J (1999) Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoact Drugs 31:171\u2013177. https:\/\/doi.org\/10.1080\/02791072.1999.10471741","journal-title":"J Psychoact Drugs"},{"key":"6065_CR112","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000376549","volume":"1","author":"M Pabba","year":"2015","unstructured":"Pabba M, Sibille E (2015) Sigma-1 and N-methyl-D-aspartate receptors: a partnership with beneficial outcomes. Mol Neuropsychiat 1:47\u201351. https:\/\/doi.org\/10.1159\/000376549","journal-title":"Mol Neuropsychiat"},{"key":"6065_CR113","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H et al (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49:655\u2013663. https:\/\/doi.org\/10.1017\/S0033291718001356","journal-title":"Psychol Med"},{"key":"6065_CR114","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/026988112098","volume":"35","author":"C Pallavicini","year":"2021","unstructured":"Pallavicini C, Cavanna F, Zamberlan F et al (2021) Neural and subjective effects of inhaled N,-N-dimethyltryptamine in natural settings. J Psychopharmacol 35:406\u2013420. https:\/\/doi.org\/10.1177\/026988112098","journal-title":"J Psychopharmacol"},{"key":"6065_CR115","volume-title":"The science of microdosing psychedelics","author":"T Passie","year":"2019","unstructured":"Passie T (2019) The science of microdosing psychedelics. Psychedelic Press, London"},{"key":"6065_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/CH-170361","volume":"70","author":"K Peto","year":"2018","unstructured":"Peto K, Nemeth N, Mester A, Magyar Z, Ghanem S, Somogyi V, Tanczos B, Deak A, Bidiga L, Frecska E, Nemes B (2018) Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N, N-dimethyltryptamine on a rat model. Clin Hemorheol Microcirc 70:107\u2013117. https:\/\/doi.org\/10.3233\/CH-170361","journal-title":"Clin Hemorheol Microcirc"},{"key":"6065_CR117","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","volume":"235","author":"L Prochazkova","year":"2018","unstructured":"Prochazkova L, Lippelt DP, Colzato LS, Kuchar M, Sjoerds Z, Hommel B (2018) Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacol 235:3401\u20133413. https:\/\/doi.org\/10.1007\/s00213-018-5049-7","journal-title":"Psychopharmacol"},{"key":"6065_CR118","unstructured":"Rands P, Joel Z, Benway T, inventors. Small Pharma Ltd, assignee. Therapeutic compounds. United States Patent US 2020\/0390746 Al, pub. Dec. 17, 2020."},{"key":"6065_CR119","unstructured":"Riba J (2003) Human pharmacology of ayahuasca. Dissertation. University of Barcelona, Spain."},{"key":"6065_CR120","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/02791072.2005.10399804","volume":"37","author":"J Riba","year":"2005","unstructured":"Riba J, Barbanoj MJ (2005) Bringing ayahuasca to the clinical research laboratory. J Psychoact Drugs 37:219\u2013230. https:\/\/doi.org\/10.1080\/02791072.2005.10399804","journal-title":"J Psychoact Drugs"},{"key":"6065_CR121","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/dta1685","volume":"7","author":"J Riba","year":"2015","unstructured":"Riba J, McIlhenny EH, Bouso JC, Barker SA (2015) Metabolism and urinary disposition of N, N-dimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal 7:401\u2013406. https:\/\/doi.org\/10.1002\/dta1685","journal-title":"Drug Test Anal"},{"key":"6065_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002130000606","volume":"154","author":"J Riba","year":"2001","unstructured":"Riba J, Rodr\u00edguez-Fornell AS, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ (2001) Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacol (Ber) 154:85\u201395","journal-title":"Psychopharmacol (Ber)"},{"key":"6065_CR123","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/jpet103049882","volume":"306","author":"J Riba","year":"2003","unstructured":"Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite secretion, and pharmacokinetics. J Pharmacol Exp Ther 306:73\u201383. https:\/\/doi.org\/10.1124\/jpet103049882","journal-title":"J Pharmacol Exp Ther"},{"key":"6065_CR124","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/02791072.2019.1602291","volume":"51","author":"AVSL Rodrigues","year":"2019","unstructured":"Rodrigues AVSL, Almeida AJ, Vieira-Coelhoa MA (2019) Dimethyltryptamine: endogenous role and therapeutic potential. J Psychoac Drugs 51:299\u2013310. https:\/\/doi.org\/10.1080\/02791072.2019.1602291","journal-title":"J Psychoac Drugs"},{"key":"6065_CR125","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00413244","volume":"5","author":"DE Rosenberg","year":"1964","unstructured":"Rosenberg DE, Isbell H, Miner EJ, Logan CR (1964) The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacol 5:217\u2013227. https:\/\/doi.org\/10.1007\/BF00413244","journal-title":"Psychopharmacol"},{"key":"6065_CR126","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/schbul\/2.1.90","volume":"2","author":"H Rosengarten","year":"1976","unstructured":"Rosengarten H, Friedhoff AJ (1976) A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances. Schizophr Bull 2:90\u2013105. https:\/\/doi.org\/10.1093\/schbul\/2.1.90","journal-title":"Schizophr Bull"},{"key":"6065_CR127","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1590\/1516-4446-2020-0884","volume":"42","author":"S Ruffell","year":"2020","unstructured":"Ruffell S, Netzband N, Bird C, Young AH, Juruena MF (2020) The pharmacological interaction of compounds in ayahuasca: a systematic review. Braz J Psychiat 42:646\u2013656. https:\/\/doi.org\/10.1590\/1516-4446-2020-0884","journal-title":"Braz J Psychiat"},{"key":"6065_CR128","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF00432428","volume":"75","author":"D Ruffing","year":"1981","unstructured":"Ruffing D, Domino EF (1981) Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat. Psychopharmacol 75:226\u2013230. https:\/\/doi.org\/10.1007\/BF00432428","journal-title":"Psychopharmacol"},{"key":"6065_CR129","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF00432112","volume":"80","author":"D Ruffing","year":"1983","unstructured":"Ruffing D, Domino EF (1983) Interaction of synthetic opioid metenkephalin peptide analogs, Lilly 127623 and FK 33\u2013824 with indole hallucinogens: antagonism of N, N-dimethyltryptamine- and LSD-induced disruption of food-rewarded bar pressing behavior in the rat. Psychopharmacol 80:315\u2013318. https:\/\/doi.org\/10.1007\/BF00432112","journal-title":"Psychopharmacol"},{"key":"6065_CR130","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00431949","volume":"62","author":"D Ruffing","year":"1979","unstructured":"Ruffing D, Kovacic B, Demetriou S, Domino EF (1979) Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat. Psychopharmacol 62:207\u2013210. https:\/\/doi.org\/10.1007\/BF00431949","journal-title":"Psychopharmacol"},{"key":"6065_CR131","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/brain\/awq367","volume":"134","author":"K Ruscher","year":"2011","unstructured":"Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L et al (2011) The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 134:732\u2013746. https:\/\/doi.org\/10.1093\/brain\/awq367","journal-title":"Brain"},{"key":"6065_CR132","doi-asserted-by":"publisher","unstructured":"Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I (2019) Neuronal sigma-1 receptors: Signaling functions and protective roles in neurodegenerative diseases. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00862","DOI":"10.3389\/fnins.2019.00862"},{"key":"6065_CR133","doi-asserted-by":"publisher","unstructured":"Samorini, G. The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: a worldwide overview . J. Psychedelic Stud. 1\u201318 (2019). doi:https:\/\/doi.org\/10.1556\/2054.2019.008","DOI":"10.1556\/2054.2019.008"},{"key":"6065_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5962\/p.168508","volume":"18","author":"RE Schultes","year":"1957","unstructured":"Schultes RE (1957) The identity of the maipighiaceous narcotics of South America. Bot Mus Leafl Harv Univ 18:1\u201356","journal-title":"Bot Mus Leafl Harv Univ"},{"key":"6065_CR135","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.pnpbp.2008.08.005","volume":"32","author":"SH Shim","year":"2008","unstructured":"Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK (2008) Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuro-Psychopharm Biol Psychiat 32:1824\u20131828. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.08.005","journal-title":"Prog Neuro-Psychopharm Biol Psychiat"},{"key":"6065_CR136","doi-asserted-by":"publisher","unstructured":"Schindler EAD, Wallace RM, Sloshower JA, D\u2019Souza DC (2018) Neuroendocrine associations underlying the persistent therapeutic effects of classic serotonergic psychedelics. Front Pharmacol https:\/\/doi.org\/10.3389\/fphar.2018.00177","DOI":"10.3389\/fphar.2018.00177"},{"key":"6065_CR137","volume-title":"Tihkal: The Continuation","author":"A Shulgin","year":"1997","unstructured":"Shulgin A, Shulgin A (1997). In: Joy D (ed) Tihkal: The Continuation. Transform Press, USA"},{"key":"6065_CR138","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/molecules25092072","volume":"25","author":"GO Silveira","year":"2020","unstructured":"Silveira GO, dos Santos RG, Louren\u00e7o FR, Rossi GN, Hallak JEC, Yonamine M (2020) Stability evaluation of DMT and harmala alkaloids in ayahuasca tea samples. Molecules 25:2072. https:\/\/doi.org\/10.3390\/molecules25092072","journal-title":"Molecules"},{"key":"6065_CR139","first-page":"549","volume":"14","author":"JR Smythies","year":"1979","unstructured":"Smythies JR, Morin RD, Brown GB (1979) Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography\/mass spectrometry. Biol Psychiat 14:549\u2013556","journal-title":"Biol Psychiat"},{"key":"6065_CR140","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1042\/BST0340600","volume":"34","author":"J Soul\u00e9","year":"2006","unstructured":"Soul\u00e9 J, Messaoudi E, Bramham CR (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans 34:600\u2013604. https:\/\/doi.org\/10.1042\/BST0340600","journal-title":"Biochem Soc Trans"},{"key":"6065_CR141","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","volume":"172","author":"RJ Strassman","year":"1984","unstructured":"Strassman RJ (1984) Adverse reactions to psychedelic drugs: a review of the literature. J Nerv Ment Dis 172:577\u2013595. https:\/\/doi.org\/10.1097\/00005053-198410000-00001","journal-title":"J Nerv Ment Dis"},{"key":"6065_CR142","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/02791072.1991.10472572","volume":"23","author":"RJ Strassman","year":"1991","unstructured":"Strassman RJ (1991) Human hallucinogenic drug research in the United States: a present-day case history and review of the process. J Psychoact Drugs 23:29\u201338. https:\/\/doi.org\/10.1080\/02791072.1991.10472572","journal-title":"J Psychoact Drugs"},{"key":"6065_CR143","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","volume":"73","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ (1996) Human psychopharmacology of N, N-dimethyltryptamine. Behav Brain Res 73:121\u2013124. https:\/\/doi.org\/10.1016\/0166-4328(96)00081-2","journal-title":"Behav Brain Res"},{"key":"6065_CR144","unstructured":"Strassman RJ (2001) DMT: the spirit molecule: a doctor\u2019s revolutionary research into the biology of near-death and mystical experiences. Park Street Press"},{"key":"6065_CR145","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","volume":"39","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ, Qualls CR, Berg LM (1996) Differential tolerance to biological and subjective effects of four closely spaced doses of N, N-dimethyltryptamine in humans. Biol Psychiat 39:784\u2013795. https:\/\/doi.org\/10.1016\/0006-3223(95)00200-6","journal-title":"Biol Psychiat"},{"key":"6065_CR146","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994a) Dose response study of N, N-dimethyltryptamine in humans: I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiat 51:85\u201397. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950020009001","journal-title":"Arch Gen Psychiat"},{"key":"6065_CR147","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994b) Dose response study of N, N-dimethyltryptamine in humans: II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98\u2013108. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950020022002","journal-title":"Arch Gen Psychiatry"},{"issue":"61","key":"6065_CR148","doi-asserted-by":"publisher","first-page":"pe12","DOI":"10.1126\/scisignal.261pe12","volume":"2","author":"TP Su","year":"2009","unstructured":"Su TP, Hayashi T, Vaupel DB (2009) When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal 2(61):pe12. https:\/\/doi.org\/10.1126\/scisignal.261pe12","journal-title":"Sci Signal"},{"key":"6065_CR149","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fphar.2018.00172","volume":"9","author":"LR Swanson","year":"2018","unstructured":"Swanson LR (2018) Unifying theories of psychedelic drug effects. Front Pharmacol 9:172. https:\/\/doi.org\/10.3389\/fphar.2018.00172","journal-title":"Front Pharmacol"},{"key":"6065_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106533","volume":"9","author":"A Szabo","year":"2014","unstructured":"Szabo A, Kovacs A, Frecska E, Rajnavolgyi E (2014) Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PLoS ONE 9:e106533. https:\/\/doi.org\/10.1371\/journal.pone.0106533","journal-title":"PLoS ONE"},{"key":"6065_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00358","author":"A Szabo","year":"2015","unstructured":"Szabo A (2015) Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00358","journal-title":"Front Immunol"},{"key":"6065_CR152","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4103\/1673-5374.179041","volume":"11","author":"A Szabo","year":"2016","unstructured":"Szabo A, Frecska E (2016) Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection? Neural Regen Res 11:396\u2013397. https:\/\/doi.org\/10.4103\/1673-5374.179041","journal-title":"Neural Regen Res"},{"key":"6065_CR153","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fnins.2016.00423","volume":"10","author":"A Szabo","year":"2016","unstructured":"Szabo A, Kovacs A, Riba J, Djurovic S, Rajnavolgyi E, Frecska E (2016) The endogenous hallucinogen and trace amine N, N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells. Front Neurosci 10:423. https:\/\/doi.org\/10.3389\/fnins.2016.00423","journal-title":"Front Neurosci"},{"key":"6065_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108612","volume":"192","author":"I Szabo","year":"2021","unstructured":"Szabo I, Varga VE, Dvoracsko S et al (2021) N, N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain. Neuropharmacol 192:108612. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108612","journal-title":"Neuropharmacol"},{"key":"6065_CR155","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF02157378","volume":"12","author":"S Sz\u00e1ra","year":"1956","unstructured":"Sz\u00e1ra S (1956) Dimethyltryptamine: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism. Experientia 12:441\u2013442. https:\/\/doi.org\/10.1007\/BF02157378","journal-title":"Experientia"},{"key":"6065_CR156","first-page":"885","volume":"20","author":"S Sz\u00e1ra","year":"1961","unstructured":"Sz\u00e1ra S (1961) Hallucinogenic effects and metabolism of tryptamine derivatives in man. Fed Proc 20:885\u2013888","journal-title":"Fed Proc"},{"key":"6065_CR157","first-page":"201","volume":"9","author":"S Sz\u00e1ra","year":"2007","unstructured":"Sz\u00e1ra S (2007) DMT at fifty. Neuropsychopharmacol Hung 9:201\u2013205","journal-title":"Neuropsychopharmacol Hung"},{"key":"6065_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/geno.1999.5960","volume":"61","author":"MA Thompson","year":"1999","unstructured":"Thompson MA et al (1999) Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics 61:285\u2013297. https:\/\/doi.org\/10.1006\/geno.1999.5960","journal-title":"Genomics"},{"key":"6065_CR159","doi-asserted-by":"publisher","first-page":"34502","DOI":"10.1074\/jbc.273.51.34502","volume":"273","author":"MA Thompson","year":"1998","unstructured":"Thompson MA, Weinshilboum RM (1998) Rabbit lung indolethylamine N-methyltransferase cDNA and gene cloning and characterization. J Biol Chem 273:34502\u201334510. https:\/\/doi.org\/10.1074\/jbc.273.51.34502","journal-title":"J Biol Chem"},{"key":"6065_CR160","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1570159X13666141210222409","volume":"13","author":"R Tittarelli","year":"2015","unstructured":"Tittarelli R, Mannocchi G, Pantano F, Romolo FS (2015) Recreational use, analysis and toxicity of tryptamines. Curr Neuropharmacol 13:26\u201346. https:\/\/doi.org\/10.2174\/1570159X13666141210222409","journal-title":"Curr Neuropharmacol"},{"key":"6065_CR161","doi-asserted-by":"publisher","first-page":"22468","DOI":"10.1073\/pnas0909089106","volume":"106","author":"SY Tsai","year":"2009","unstructured":"Tsai SY, Hayashi T, Harvey BK, Wang Y, Wu WW, Shen RF et al (2009) Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway. Proc Natl Acad Sci USA 106:22468\u201372243. https:\/\/doi.org\/10.1073\/pnas0909089106","journal-title":"Proc Natl Acad Sci USA"},{"key":"6065_CR162","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1503\/cmaj.141124","volume":"187","author":"KW Tupper","year":"2015","unstructured":"Tupper KW, Wood E, Yensen R, Johnson MW (2015) Psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ\u202f: Canadian Medical Association Journal 187:1054\u20131059. https:\/\/doi.org\/10.1503\/cmaj.141124","journal-title":"CMAJ : Canadian Medical Association Journal"},{"key":"6065_CR163","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/archneurpsyc.1959.02340130141020","volume":"81","author":"WJ Turner","year":"1959","unstructured":"Turner WJ, Merlis S (1959) Effects of some indolealkylamines in man. AMA Arch Neurol Psychiat 81:121\u2013129. https:\/\/doi.org\/10.1001\/archneurpsyc.1959.02340130141020","journal-title":"AMA Arch Neurol Psychiat"},{"key":"6065_CR164","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya VA, Marek GJ, Aghajanian GK, Duman RS (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17:2785\u20132795. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-08-02785.1997","journal-title":"J Neurosci"},{"key":"6065_CR165","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1002\/ejoc.201201122","volume":"36","author":"R Vianello","year":"2012","unstructured":"Vianello R, Repi\u010d M, Mavri J (2012) How are biogenic amines metabolized by monoamine oxidases? Eur J Org Chem 36:7057\u20137065. https:\/\/doi.org\/10.1002\/ejoc.201201122","journal-title":"Eur J Org Chem"},{"key":"6065_CR166","volume-title":"A really good day: how microdosing made a mega difference in my mood, my marriage, and my life","author":"A Waldman","year":"2017","unstructured":"Waldman A (2017) A really good day: how microdosing made a mega difference in my mood, my marriage, and my life. Alfred A Knopf, New York"},{"key":"6065_CR167","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1471-4159.1983.tb08113.x","volume":"40","author":"MR Whipple","year":"1983","unstructured":"Whipple MR, Reinecke MG, Gage FH (1983) Inhibition of synaptosomal neurotransmitter uptake by hallucinogens. J Neurochem 40:1185\u20131188. https:\/\/doi.org\/10.1111\/j.1471-4159.1983.tb08113.x","journal-title":"J Neurochem"},{"key":"6065_CR168","doi-asserted-by":"publisher","unstructured":"Yaden DB, Griffiths RR (2021) The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol. Transl. Sci. doi:https:\/\/doi.org\/10.1021\/acsptsci.0c00194","DOI":"10.1021\/acsptsci.0c00194"},{"key":"6065_CR169","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","volume":"236","author":"S Yanakieva","year":"2019","unstructured":"Yanakieva S, Polychroni N, Family N, Williams LT, Luke DP, Terhune DB (2019) The effects of microdose LSD on time perception: a randomized, double blind, placebo-controlled trial. Psychopharmacol 236:1159\u20131170. https:\/\/doi.org\/10.1007\/s00213-018-5119-x","journal-title":"Psychopharmacol"},{"key":"6065_CR170","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.expneurol.2009.10.019","volume":"221","author":"ZJ Yang","year":"2010","unstructured":"Yang ZJ, Carter EL, Torbey MT, Martin LJ, Koehle RC (2010) Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase\/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 221:166\u2013174. https:\/\/doi.org\/10.1016\/j.expneurol.2009.10.019","journal-title":"Exp Neurol"},{"key":"6065_CR171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s1570-0232(02)00397-5","volume":"779","author":"M Yritia","year":"2002","unstructured":"Yritia M, Riba J, Ortuno J, Ramirez A, Castillo A, Alfaro Y et al (2002) Determination of N, N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of ayahuasca. J Chromatogr B 779:271\u2013281. https:\/\/doi.org\/10.1016\/s1570-0232(02)00397-5","journal-title":"J Chromatogr B"},{"key":"6065_CR172","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10495-018-1495-2","volume":"24","author":"X Zhao","year":"2019","unstructured":"Zhao X, Zhu L, Liu D et al (2019) Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia\/reperfusion injury. Apoptosis 24:157\u2013167. https:\/\/doi.org\/10.1007\/s10495-018-1495-2","journal-title":"Apoptosis"}],"updated-by":[{"DOI":"10.1007\/s00213-022-06084-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000}}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06065-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:24:02Z","timestamp":1744197842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":172,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6065"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06065-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00213-022-06084-x","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00213-022-06084-x","URL":"https:\/\/doi.org\/10.1007\/s00213-022-06084-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}